WHO INFORME 58 - ABRIL 2025 - TRS 1060





Link para descargar el documento

 https://iris.who.int/bitstream/handle/10665/381072/9789240108264-eng.pdf?sequence=1


WHO TRS 1060 INFORME 58

Annex 1
Guidelines and guidance texts adopted by the Expert Committee on Specifications for
Pharmaceutical Preparations 

Annex 2
WHO good practice considerations for the prevention and control of nitrosamines in
pharmaceutical products 

Annex 3 
WHO good manufacturing practices for excipients used in pharmaceutical products 

Annex 4 
Good practices for blood establishments 

Annex 5 
WHO Biowaiver List: proposal to waive in vivo bioequivalence requirements for WHO
Model List of Essential Medicines immediate-release, solid oral dosage forms 

Annex 6
Guideline on bioanalytical method validation and study sample analysis 

Annex 7
Good practices of national regulatory authorities in implementing the collaborative
registration procedures for medical products 

Annex 8
Collaborative registration procedure between WHO and national regulatory
authorities in the assessment and accelerated national registration of
WHO-prequalified vector control products 

Annex 9
Guidance for the graphic representation of chemical structures of pharmaceutical
substances in the publications of International Nonproprietary Names and
The International Pharmacopoeia 



WHO TRS 1060 INFORME 58




Entradas populares de este blog

FERIA DEL COLECCIONISMO - CLUB FILATÈLICO GUAYAQUIL

ACUMULACIÒN DE GRASA ABDOMINAL EN HOMBRES MAYORES DE 55 AÑOS